Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1059

Lacto-N-neotetraose

Intended Use: Intended for use as an ingredient in exempt infant formula for term infants with cow milk protein allergy, multiple food allergies, non-allergenic gut impairment, and malabsorptive conditions at a level up to 600 mg/L as consumed.
Basis: Scientific procedures
Notifier: Glycom A/S
Notifier Address: Kogle Allé 4
2970 Hørsholm
Denmark
GRAS Notice (releasable information): GRN 1059 with amendments (in PDF) (2.8 MB)
Date of closure: Dec 2, 2022
FDA's Letter: FDA has no questions (in PDF) (288 kB)
-
-